BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23065847)

  • 1. Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.
    Beierle EA; Ma X; Stewart JE; Megison M; Cance WG; Kurenova EV
    Mol Carcinog; 2014 Mar; 53(3):230-42. PubMed ID: 23065847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
    Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA
    Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.
    Garces CA; Kurenova EV; Golubovskaya VM; Cance WG
    Cancer Res; 2006 Feb; 66(3):1446-54. PubMed ID: 16452200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.
    Beierle EA; Ma X; Trujillo A; Kurenova EV; Cance WG; Golubovskaya VM
    Mol Carcinog; 2010 Mar; 49(3):224-34. PubMed ID: 19885861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
    Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
    Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
    Chen H; Suo K; Cheng Y; Zheng B; Xu L
    Gynecol Endocrinol; 2013 Jan; 29(1):20-4. PubMed ID: 22817694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway.
    Lee HK; Chauhan SK; Kay E; Dana R
    Blood; 2011 May; 117(21):5762-71. PubMed ID: 21460247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
    Kurenova E; Liao J; He DH; Hunt D; Yemma M; Bshara W; Seshadri M; Cance WG
    Oncotarget; 2013 Oct; 4(10):1632-46. PubMed ID: 24142503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 90β stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cells.
    Xiong X; Wang Y; Liu C; Lu Q; Liu T; Chen G; Rao H; Luo S
    Exp Cell Res; 2014 Aug; 326(1):78-89. PubMed ID: 24880126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
    Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
    Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.
    Abu-Ghazaleh R; Kabir J; Jia H; Lobo M; Zachary I
    Biochem J; 2001 Nov; 360(Pt 1):255-64. PubMed ID: 11696015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth.
    Ucar DA; Kurenova E; Garrett TJ; Cance WG; Nyberg C; Cox A; Massoll N; Ostrov DA; Lawrence N; Sebti SM; Zajac-Kaye M; Hochwald SN
    Cell Cycle; 2012 Sep; 11(17):3250-9. PubMed ID: 22894899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.
    Kim B; van Golen CM; Feldman EL
    Neoplasia; 2003; 5(5):405-16. PubMed ID: 14670178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor gangliosides on tyrosine phosphorylation of p125FAK in platelet adhesion to collagen.
    Chen YX; Chen XW; Li CG; Yue LJ; Mai HR; Wen FQ
    Oncol Rep; 2013 Jan; 29(1):343-8. PubMed ID: 23117335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
    Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
    Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
    Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
    Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of focal adhesion kinase on the motility, proliferation and apoptosis of Caco2 and SMMC-7721 cells.
    Gao N; He H; Xiao L; Gao X; Shi H; Wu Q; Xu N; Lei Y; Song X; Hou Y
    Med Oncol; 2015 Apr; 32(4):125. PubMed ID: 25790781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNARE-mediated membrane traffic is required for focal adhesion kinase signaling and Src-regulated focal adhesion turnover.
    Skalski M; Sharma N; Williams K; Kruspe A; Coppolino MG
    Biochim Biophys Acta; 2011 Jan; 1813(1):148-58. PubMed ID: 20888376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
    Stafman LL; Williams AP; Marayati R; Aye JM; Markert HR; Garner EF; Quinn CH; Lallani SB; Stewart JE; Yoon KJ; Whelan K; Beierle EA
    Sci Rep; 2019 Sep; 9(1):13259. PubMed ID: 31519958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.
    Kurenova EV; Hunt DL; He D; Magis AT; Ostrov DA; Cance WG
    J Med Chem; 2009 Aug; 52(15):4716-24. PubMed ID: 19610651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.